Patients who took Eli Lilly's weight loss drug Zepbound regained around half the weight they lost after stopping the newly approved treatment for a year, according to new data.
The House passed a relatively major healthcare package late Monday, an end-of-year victory after the same policies had to be yanked from consideration in September because they lacked bipartisan support.
A Louisiana federal judge on Friday largely rejected Novo Nordisk's bid to dismiss one of the earliest lawsuits brought against the pharmaceutical company over side effects of its blockbuster drug Ozempic.
Medicare negotiations of prescription drug prices could have cut seniors' out-of-pocket costs by nearly a quarter had the program been in effect in 2021.
The deal marks the second billion-dollar acquisition by AbbVie in under a week. The company also acquired Immunogen and its ovarian cancer treatment for $10 billion.